Colorectal cancer is a common and significant public health concern. The liver is the most common site of metastasis, and colorectal cancer liver metastases (CRLM) may affect up to 60% of patients at some time during the course of their disease.

Metastatic colorectal cancer is a prevalent disease for which many new therapies have been developed over the past decade.

This article reviews the various systemic therapy options for patients with metastatic colorectal cancer (CRC) that is judged to be noncurable. The choice of initial therapy depends on patient preferences, treatment goals, performance status, and presence of comorbid conditions.

This article addresses the misconception that patients with cancer should undergo a definitive “transition” to palliative care at some point in their trajectory, and instead proposes that a gradual shift should occur from primary palliative care provided by the oncologist to specialty palliative

Sequencing therapy in the metastatic setting is challenging and requires that clinicians consider overlapping mechanisms of action and toxicity profiles when selecting among agents.  Clinicians need to be aware of the new data, new FDA approvals, and new changes in the guideline recommendations f

The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

Join Al B. Benson III, MD (Medical Oncologist) and William Small, Jr., MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to colon cancer.

The 2013 Nursing Program: Advancing Oncology Nursing™ webinar series provides the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.

Join Al B. Benson III, MD (Medical Oncologist) and William Small, Jr., MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to colon cancer.

Presented by Alan P. Venook, MD, this recorded webcast will explore emerging treatments and research articles on metastatic colorectal cancer pipelines. In addition, the webinar will address the safety and efficacy of each emerging treatment, as well as their mechanism of action.